Revolution Medicines Inc.-28RVMDWPreferred / convertible
13F holders, Q1 2024 (March 31)24holders
2famous investors
$0.22avg. 13F price*
At the end of Q1 2024, 24 institutions reported holding Revolution Medicines Inc.-28 (RVMDW) in their 13F filings. The largest holders were LMR Partners LLP ($399K), Boothbay Fund Management, LLC ($262K) and D. E. Shaw & Co. ($216K). 2 famous investors held it, including David E. Shaw ( of D. E. Shaw & Co.'s portfolio) and Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Revolution Medicines Inc.-28
- CUSIP
- 76155X118
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $404K |
| Exits | 1 | $133 |
Ownership 24 holders
| LMR Partners LLP | — | New | 2,185,658 | $399K |
| Boothbay Fund Management, LLC | — | No change | 8,144 | $262K |
| D. E. Shaw & Co. | — | No change | 1,347,439 | $216K |
| T. Rowe Price Associates Inc. | — | Reduce -0.2% | 607,436 | $98K |
| Adage Capital Partners Gp, L.L.C. | — | No change | 500,000 | $91K |
| Soros Capital Management LLC | — | No change | 364,824 | $67K |
| Walleye Capital LLC | — | Reduce -40.2% | 356,667 | $65K |
| Perceptive Advisors LLC | — | No change | 250,000 | $46K |
| Bleichroeder LP | — | No change | 200,000 | $37K |
| Cowen and Company, LLC | — | Reduce -0.1% | 199,800 | $36K |
| Sculptor Capital LP | — | No change | 178,107 | $34K |
| Davidson Kempner Capital Management LP | — | No change | 150,000 | $28K |
| CSS LLC | — | Add +25.0% | 14,856 | $24K |
| Magnetar Financial LLC | — | No change | 119,289 | $22K |
| Farallon Capital Management, L.L.C. | — | No change | 120,085 | $19K |
| DLK Investment Management, LLC | — | No change | 77,000 | $14K |
| Wolverine Asset Management LLC | — | No change | 70,349 | $13K |
| Weiss Asset Management LP | — | No change | 73,640 | $12K |
| TD Asset Management Inc | — | No change | 40,636 | $7K |
| Citadel Advisors | — | New | 33,722 | $5K |
| Texas Yale Capital Corp. | — | No change | 10,000 | $2K |
| CoreCap Advisors, LLC | — | New | 100 | $18 |
| UBS Group AG | — | Reduce -90.6% | 91 | $17 |
| Osaic Holdings, Inc. | — | No change | 4 | $0 |
"% of holder's portfolio" is RVMDW's weight in each manager's 13F, not the share of Revolution Medicines Inc.-28 the manager owns.